Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
87794
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
||
|
FDA ORPHAN DRUG |
280809
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/09/657
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
||
|
NDF-RT |
N0000175823
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
||
|
WHO-ATC |
A16AB12
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
ELOSULFASE ALFA (AUTHOURIZED: MUCOPOLYSACCHARIDOSIS IV)
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C174795
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
100000156646
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
9686
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
SUB129547
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
ALTERNATIVE | |||
|
1489914
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | RxNorm | ||
|
CHEMBL2108676
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
m11740
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
9025-60-9
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
DB09051
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
SUB130626
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
ODJ69JZG85
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
ODJ69JZG85
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
Elosulfase alfa
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
YY-129
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
7392
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY | |||
|
4999
Created by
admin on Mon Mar 31 21:42:38 GMT 2025 , Edited by admin on Mon Mar 31 21:42:38 GMT 2025
|
PRIMARY |
ACTIVE MOIETY